47 results
Page 2 of 3
8-K
EX-10.2
8fx3wpt1
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am
8-K
EX-10.1
b83lrqg1 wu8r9w6958
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am
8-K
EX-2.1
x6rl7ltzd czfpu
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am
8-K
EX-99.1
tgmxyxy
30 May 23
Talaris Therapeutics Announces Leadership Transition
4:51pm
8-K
EX-10.1
xxa6hndpgk8mbbts76r
14 Apr 23
Cost Associated with Exit or Disposal Activities
5:20pm
S-3
475k36
15 Aug 22
Shelf registration
5:06pm
DEF 14A
ll9 iebxw6b092
29 Apr 22
Definitive proxy
4:24pm
10-K
7ghcqrv
17 Mar 22
Annual report
4:31pm
10-Q
m7cjhl0m665g
14 Jun 21
Quarterly report
4:21pm
8-K
EX-3.2
nr8chj
11 May 21
Amendments to Articles of Incorporation or Bylaws
4:00pm
424B4
d5mvi
10 May 21
Prospectus supplement with pricing info
4:20pm
S-1/A
ljtfvu
3 May 21
IPO registration (amended)
6:07am
S-1/A
EX-10.3
b7rw0r8
3 May 21
IPO registration (amended)
6:07am
S-1/A
EX-3.1
yl4z6kh
3 May 21
IPO registration (amended)
6:07am
S-1/A
EX-3.4
txkdtzf
3 May 21
IPO registration (amended)
6:07am